Immunotherapy targeting PD-1/PD-L1 has been used or attempted in the treatment of many solid tumors, such as lung cancer, advanced metastatic melanoma, esophageal cancer, and colorectal cancer [248,249]. The gene discussed is CD274; the disease is esophageal cancer.